In the following video, Motley Fool health-care analyst David Williamson takes investors through what to expect from Bristol-Myers Squibb's (NYSE:BMY) upcoming earnings report and the important things to watch from this company moving forward.
David Williamson owns shares of Pfizer. The Motley Fool recommends Gilead Sciences. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.